key: cord-0905229-q9xu3lwd
authors: Lopez‐Marco, Ana; Harky, Amer; Malvindi, Pietro G.; Verdichizzo, Danilo; McPherson, Iain; Roman, Marius; Oo, Aung; Ohri, Sunil
title: Type A aortic syndromes in COVID‐19 positive patients: Case series from a UK multicentre study
date: 2021-05-12
journal: J Card Surg
DOI: 10.1111/jocs.15625
sha: 246960cdc3e7d6207885f4b7ca58fb65eaa9e10d
doc_id: 905229
cord_uid: q9xu3lwd

OBJECTIVE: The coronavirus disease (COVID‐19) increases the respiratory complications and carries a higher mortality in the immediate postoperative period. The aim of this study was to analyze the outcomes of patients with type A acute aortic syndromes (AAS) diagnosed with COVID‐19 in the perioperative period. METHODS: Retrospective analysis of prospectively collected data between March and August 2020 from 20 participating cardiac surgery centers in the United Kingdom. RESULTS: Among 122 patients who underwent emergency surgical repair for type A AAS at the participating centers, 3 patients (2.5%) tested positive for COVID‐19 in the preoperative screeing, and 4 cases turned to be positive in the postoperative period having been operated on an unknown COVID‐19 status. Another patient was diagnosed of COVID‐19 disease based on radiological features. These eight patients had increased postoperative complications, including respiratory failure, longer ventilation times, and Intensive Therapy Unit (ITU) stay and increased mortality when compared with COVID‐19 negative patients. CONCLUSION: COVID‐19 disease in the perioperative period of type A AAS poses a challenge. Despite the increasing morbidity and mortality associated with the virus, the prognosis of the aortic disease is poorer and emergency surgery should not be contraindicated based on the COVID‐19 diagnosis alone.

each hour) if not treated immediately. 1, 2 Hence, when a COVID-19 screening fast test is not available, emergency aortic surgery with universal personal protective equipment (PPE) precautions is advised, as the risk of aortic rupture and death outweighs the risk of COVID-19 in the postoperative period. 3 When there is a confirmed COVID-19 result preoperatively, one has to balance the risks of the two diseases. Our approach has been to offer emergency aortic surgery to those individuals who despite a positive COVID-19 test, do not present any symptoms of the disease (i.e., fever and respiratory insufficiency) and pass a "fitness for surgery" assessment. 3 The aim of this study was to analyze early outcomes of COVID-19 positive patients with acute type A AAS who had undergone emergency surgery for aortic repair.

Retrospective analysis of prospectively collected data from a multicentre study with 20 participating aortic centers from the UK (66% of the aortic units in the country, including the largest specialized aortic centers and covering most of the geographical areas), designed to assess the impact of the COVID-19 pandemic in the delivery of services for aortovascular disease in the UK between March and August 2020.

The other 14 aortic units declined to participate in the study for different reasons including inability to provide emergency surgery cover during the COVID-19, insufficient resources to collect the data and/or individual preferences.

In this substudy, we concentrate in patients who were admitted to specialized aortic units with the diagnosis of acute type A AAS: either aortic dissection (AD), intramural hematoma (IMH) or penetrating aortic ulcer (PAU) and tested positive for COVID-19 in the PCR-RNA analysis or had lung parenchyma changes suggestive of COVID-19 disease in the non-contrast CT scan during the perioperative period.

Patients who were turned down for surgery or those presenting with other diagnosis, including type B AAS, were excluded from this substudy.

We report demographics and clinical outcomes, including respiratory complications, length of intensive care (Intensive Therapy Unit [ITU]) stay, and mortality.

Between March and August 2020, 122 patients were admitted with a diagnosis of type A AAS and offered emergency surgical repair at the participating centers.

The preoperative COVID-19 screening protocol consisted of two consecutive nasopharyngeal swabs for PCR-RNA analysis and a noncontrast CT chest to assess changes in the lung parenchyma. 3 Thirty-three patients (27%) had a confirmed negative test before the start of the surgical procedure, while in 3 patients (2.5%), the test resulted positive for COVID-19. The majority of the patients (70.5%, n = 86) were operated on an unknown COVID-19 status which ultimately turned to be positive in four cases ( Table 1 ).

The analysis of the noncontrast windows of the preoperative CT chest revealed changes in the lung parenchyma suggestive of COVID-19 disease (i.e., acute diffuse ground glass opacities) in only two patients (1.6%). One of these patients was referred with a negative COVID-19 test but tested positive after surgery (Table 1) They were all young fit females (mean age: 52.7 years, 52-53), with no significant comorbidities apart from hypertension and smoking T A B L E 1 Demographics, aortovascular diagnosis, and details of the preoperative screeining for COVID-19 habitus. Diagnosis was: type A IMH (n = 2) and type A AD (n = 1), all of them extending from the aortic root to the iliacs. One patient had Turner Syndrome and had a known root aneurysm (65 mm) and another patient had a known bicuspid aortic valve (Table 1) .

All three received emergency surgery without any delays. Only one patient required reintubation and tracheostomy due to progressive respiratory failure (Table 2 ). (Table 1 ).

There were no respiratory complications in this group, but one of the patients died of neurological complications ( Table 2 ).

In our series, those who underwent AAS repair being COVID-19

positive or with signs of acute lung disease, had a higher incidence of respiratory complications, compared with those who were COVID-19 negative.

We report 37.5% reintubation rate and 25% of tracheostomy in our COVID-19 patients when compared with those COVID-19 negative (7.5% reintubation, 10% tracheostomy). 

The pathogenesis of COVID-19 is complex and includes activation of the systemic inflammation cascade and prothrombotic effects that manifest as heterogenous organ damage and a highly variable clinical course. 4, 5 Cardiac surgery, with the use of extracorporeal circulation, causes similar T A B L E 2 Postoperative respiratory complications, length of stay, and status at discharge for the corresponding patients listed in With only a few reports available in the literature, [9] [10] [11] [12] there is limited evidence to drive valid conclusions about prognosis and outcomes for patients with AAS and COVID-19 disease, and to establish clear recommendations for their management.

However, even from these limited number of reports, delayed postoperative respiratory failure requiring reintubation and tracheostomy seems to be a frequent complication in the immediate postoperative period. In addition, complications derived from an altered coagulation system-either excessive bleeding or prothrombotic effecthave also been described. [9] [10] [11] [12] The majority of PCR-RNA analysis tests used in the different parti- Based on the assumption that COVID-19 status may play a signifcant role in exacerbating the expected complications after major aortic surgery, it is paramount to assess the patients' physiological reserve before the operation, 12 with the expectation of deranged hematological and inflammatory responses, 9, 12 as well as potential respiratory complications. 10, 11 The consensus from the participating centers, was that young The decision to operate in elderly patients should be made on an individual basis, balancing the existence of other comorbidities with COVID status and existing complications if any. We did not turn down for surgery any patients with AAS based on COVID-19 status alone. 13 Furthermore, the resources needed in the immediate postoperative period for these complicated cases (multiple organ support, ITU resources) in the midst of a pandemic with its shortages, have also to be considered.

Surgical mortality in these group of patients is higher than for those without COVID-19 (25% vs. 12% in our series), but still better than the alternative with conservative treatment. 1, 2 There are several limitations associated with out study, including the small sample size in this subcohort of patients and the variation in practice among the participating centers.

Diagnosis of COVID-19 disease in the perioperative period of type A AAS poses a challenge to the management of these patients. Despite the increasing morbidity and mortality associated with the virus, the prognosis of the aortic disease is poorer and emergency surgery

should not be contraindicated based on the COVID-19 diagnosis alone.

M. Kuduvalli, M. Field (Liverpool Heart and Chest Hospital

Manchester Royal Infirmary)

Acute aortic syndromes

ESC Guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Daignsosi and Treatment of Aortic Diseases of the European Society of Cardiology (ESC)

The fate of patients with acute aortic syndromes during the coronavirus (COVID-19) pandemic: a UK multicenter study. JTCVS Open

The four horsemen of a viral Apocalypse: the pathogenesis of SARS-CoV-2 infection (COVID-19)

Clinical characteristics of coronavirus disease 2019 in China

Outcomes of patients diagnosed with COVID-19 in the postoperative period following cardiac surgery

Cardiac surgery outcomes in patients with coronavirus disease 2019 (COVID-19): a case-series report

Early respiratory outcomes following cardiac surgery in patients with COVID-19

Acute aortic dissection surgery in a patient with COVID-19

Surgical management of thoracic aortic emergency with pre-and postoperative COVID-19 disease

Acute type A aortic dissection complicated by COVID-19 infection

Type A aortic dissection during COVID-19 pandemic: report from tertiary aortic centers in the United States and China

Turn down of acute aortic syndrome cases during COVID-19: results from UK multicentre studies